Papers
1
Total Citations
4
H-Index
1
About
Ishan Patel is a clinician-researcher advancing the frontiers of radiation oncology, with a primary focus on stereotactic ablative radiotherapy (SABR) for early-stage breast cancer. His most notable contribution stems from a Phase I clinical trial investigating a single-fraction, pre-operative ablative approach—a paradigm-shifting strategy designed to reduce treatment burden while maintaining oncologic outcomes. This work, published in 2023, has already garnered 4 citations, signaling early recognition within the field for its innovative design and potential to reshape breast cancer management. Patel’s research integrates precision dosimetry with surgical timing, aiming to minimize toxicity and improve patient quality of life. His contributions are particularly impactful for students and researchers interested in hypofractionation, translational oncology, and the intersection of radiation biology with surgical oncology. By challenging conventional fractionation schedules, Patel is helping to define a new standard for ultra-hypofractionated therapy in breast cancer.
Research Focus
Key Achievements
Top Papers
- 1